A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 321 participants.

Also called NCT02741245

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 321 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02741245
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02741245. Randomized; double masking; primary purpose treatment. Start 2016-06-09 (actual); primary completion 2017-01-18 (actual). Results posted on 2018-03-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the Efficacy and Safety of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-832)
Condition
Hypercholesterolemia
Intervention (Drug)
Ezetimibe 10 mg
Intervention (Drug)
Rosuvastatin 2.5 mg
Intervention (Drug)
Placebo for Ezetimibe
Intervention (Drug)
Placebo for Rosuvastatin
Lead sponsor
Organon and Co (class: industry)

Record details

Record id
cardio:ct-nct02741245
Content hash
28c54a4dad8a658679205f748da5e18260ccbec616e27d38db4bc32532efccc2